l General Information |
Product Name | Acipimox |
General description | Acipimox is a niacin derivative used as a hypolipidemic agent. |
Synonym | Olbemox; 5-methyl-4-oxidopyrazin-4-ium-2-carboxylic acid |
Purity | ≥98.0%(HPLC) | CAS Number | 51037-30-0 |
Formula | C6H6N2O3 | Molecular Weight | 154.125 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White to Faint Yellow Solid |
Solubility(25°C) | DMSO | ≥15mg/mL |
Ethanol | Slightly soluble |
Water | ≥15mg/mL |
l Biological Information |
Biochem/Physiol
Actions | Acipimox is a niacin derivative and nicotinic acid analog with activity as a hypolipidemic agent. Acipimox has special application for the treatment of hyperlipidemia in non-insulin-dependent diabetic patients. |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
